CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, June 17th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...